Transcatheter Treatment of Aortopulmonary Window with a Symmetrical Membranous Ventricular Septal Occluder

Xu, Haixia; Zheng, Duo; Pan, Min; Li, Xiaofei

doi:10.1159/000475706

Cited by 3 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Various devices, coils, vascular plug, symmetrical membranous ventricular septal occluder have been used to occlude APW. 22 Firstly, transcatheter closure of postsurgical residual defects was reported. 23 Later on; Nayak et al 24 shared their experience of transcatheter native congenital APW closure via antegrade and retrograde routes using ADO II.…”

Section: Discussionmentioning

confidence: 99%

Off-label Use of ADO II® in the Closure of Various Congenital Heart Defects

Pamukçu¹,

Sunkak

Tuncay

et al. 2022

JPA

View full text Add to dashboard Cite

Devices may be used for special purposes different than their production purpose. For instance, Amplatzer Ductal Occluder is actually designed for duct closure and its usage for closing defects other than ductus is named as off-label. The aim of this study is to emphasize off-label use of device: not only for PDA and VSD but also for other various defects. This study is designed retrospectively, performed by the evaluation catheterization records of patients in whom ADO II and ADO II-AS devices were used in Erciyes University Medical Faculty Children Hospital, Pediatric Cardiology Department between 2011 and 2018. Patients’ demographic criteria: age, weight at the time of procedure was gathered. The diagnosis, size of device, follow-up period and complications were also noted. From April 2011 to March 2018, a total of 121 patients underwent transcatheter closure by ADO II and 66 patients by ADO II AS. The number of PDA closure with ADO II was 48; with ADO II AS were 62. Rest of the procedures were all off-label. Types of off-label procedures performed were: VSD closure, residual mitral cleft closure, Aorta-Right atrium tunnel closure, pulmonary arteriovenous fistula occlusion, aorta-pulmonary window closure, and occlusion of the artery feeding accessory lobe in scimitar syndrome, Gerbode defect occlusion. Up to our knowledge; this study includes the largest pediatric case series with various different congenital heart defects which were closed with ADO-II. Also our ADO-II occluded VSD case series is one of the largest series in the literature with almost 6 years’ follow-up. We believe in that ADO-II device may be an alternative in percutaneous closure of various rare heart defects. It is used successfully for non-ductal defects with low complication and high compliance rates.

show abstract

Section: Discussionmentioning

confidence: 99%

Off-label Use of ADO II® in the Closure of Various Congenital Heart Defects

Pamukçu¹,

Sunkak

Tuncay

et al. 2022

JPA

View full text Add to dashboard Cite

show abstract

Transcatheter closure of congenital aortopulmonary window in young children: Debating on the occluder devices application

Wang

et al. 2022

Asian Journal of Surgery

View full text Add to dashboard Cite

Percutaneous closure of an aortopulmonary window in a young adult patient: a case report of transcatheter closure with an occluder device

Giordano

Butera

2020

European Heart Journal - Case Reports

View full text Add to dashboard Cite

Background Aortopulmonary window is a congenital heart disease requiring a surgical approach to achieve a complete correction. Case summary We report on a case of a young female symptomatic adult patient with a significant aortopulmonary window. The patients refused surgical approach and since the defect was far enough from the pulmonary and aortic valve a percutaneous approach was proposed. The large aortopulmonary window was closed effectively with an Amplatzer Muscular Septal Occluder device (Abbott, Plymouth, MN, USA). At 1-year follow-up, the device was in a good position with no residual shunt. Discussion Transcatheter closure of an aortopulmonary window is an effective and safe procedure in specific anatomic defects.

show abstract

Transcatheter Treatment of Aortopulmonary Window with a Symmetrical Membranous Ventricular Septal Occluder

Cited by 3 publications

References 10 publications

Off-label Use of ADO II® in the Closure of Various Congenital Heart Defects

Off-label Use of ADO II® in the Closure of Various Congenital Heart Defects

Transcatheter closure of congenital aortopulmonary window in young children: Debating on the occluder devices application

Percutaneous closure of an aortopulmonary window in a young adult patient: a case report of transcatheter closure with an occluder device

Contact Info

Product

Resources

About